The International Society of Nephrology (ISN) - The ISN-ACT Clinical Trials Toolkit is an open-access, online resource to assist clinical research studies and trial site participation. Step-by-step guidance and best practices in: •
![Study designs of registered clinical trials of products for SARS-CoV-2... | Download Scientific Diagram Study designs of registered clinical trials of products for SARS-CoV-2... | Download Scientific Diagram](https://www.researchgate.net/publication/342062048/figure/fig2/AS:903926408814593@1592524258628/Study-designs-of-registered-clinical-trials-of-products-for-SARS-CoV-2-infection-n201.png)
Study designs of registered clinical trials of products for SARS-CoV-2... | Download Scientific Diagram
![Opening clinical trial data: are the voluntary data-sharing portals enough? | BMC Medicine | Full Text Opening clinical trial data: are the voluntary data-sharing portals enough? | BMC Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12916-015-0525-y/MediaObjects/12916_2015_525_Fig1_HTML.gif)
Opening clinical trial data: are the voluntary data-sharing portals enough? | BMC Medicine | Full Text
![A critical appraisal of clinical trials conducted and subsequent drug approvals in India and South Africa | BMJ Open A critical appraisal of clinical trials conducted and subsequent drug approvals in India and South Africa | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/5/8/e007304/F1.large.jpg)
A critical appraisal of clinical trials conducted and subsequent drug approvals in India and South Africa | BMJ Open
![Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d5d7c187-2f1d-4f07-a0dd-825d6633f582/gr1.jpg)
Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology
![Schematic view of an open label extension to a randomized controlled... | Download Scientific Diagram Schematic view of an open label extension to a randomized controlled... | Download Scientific Diagram](https://www.researchgate.net/profile/Melissa-Maguire-4/publication/229531788/figure/fig1/AS:280360760954899@1443854622269/Schematic-view-of-an-open-label-extension-to-a-randomized-controlled-clinical-trial.png)
Schematic view of an open label extension to a randomized controlled... | Download Scientific Diagram
![Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials. - The Lancet Regional Health – Americas Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials. - The Lancet Regional Health – Americas](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0d8e80f2-4b6d-42a0-acb8-c0cc44efa807/gr1.jpg)
Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials. - The Lancet Regional Health – Americas
![How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download](https://images.slideplayer.com/23/6590870/slides/slide_3.jpg)